Clinical Trial Update: A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2 multisite dose-finding and expansion study of WTX-330 in adults with selected advanced or metastatic solid tumors or Non-Hodgkin lymphoma. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• WTX-330

Snippet

Sponsor: Werewolf Therapeutics, Inc. | Conditions: Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING